{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:55:57Z","timestamp":1794009357443,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","award":["13031"],"award-info":[{"award-number":["13031"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.radonc.2023.109950","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T13:13:46Z","timestamp":1696943626000},"page":"109950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Microbiome and metabolome dynamics during radiotherapy for prostate cancer"],"prefix":"10.1016","volume":"189","author":[{"given":"Willeke","family":"Danckaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Spaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Sundahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"De Bruycker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"De Wagter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109950_b0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2013.08.021","article-title":"Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy","volume":"109","author":"Van Praet","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0010","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150930","article-title":"Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer","volume":"89","author":"Ishii","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109950_b0015","doi-asserted-by":"crossref","unstructured":"Groen VH, Zuithoff NPA, van Schie M, Monninkhof EM, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp J, Pos FJ, Smeenk RJ, Haustermans K, Isebaert S, Draulans C, Depuydt T, Verkooijen HM, van der Heide UA, Kerkmeijer LGW. Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial. Radiother Oncol. 2021;162:98-104.","DOI":"10.1016\/j.radonc.2021.06.033"},{"key":"10.1016\/j.radonc.2023.109950_b0020","doi-asserted-by":"crossref","unstructured":"Bai J, Barandouzi ZA, Rowcliffe C, Meador R, Tsementzi D, Bruner DW. Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review. Front Oncol. 2021;11.","DOI":"10.3389\/fonc.2021.745262"},{"key":"10.1016\/j.radonc.2023.109950_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2020.10.033","article-title":"The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review","volume":"156","author":"Tonneau","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.euo.2019.07.005","article-title":"Plasma metabolomic profiles and risk of advanced and fatal prostate cancer","volume":"4","author":"Wang","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.radonc.2018.06.022","article-title":"Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer","volume":"128","author":"Jia","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2021.07.1713","article-title":"Impact of pelvic radiation therapy for prostate cancer on global metabolic profiles and microbiota-driven gastrointestinal late side effects: A longitudinal observational study","volume":"111","author":"Ferreira","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.radonc.2015.07.037","article-title":"Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms","volume":"117","author":"Chai","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.radonc.2023.109950_b0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2006.05.037","article-title":"Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer","volume":"66","author":"Wang-Chesebro","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0060","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.prro.2013.01.003","article-title":"Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate","volume":"3","author":"Hall","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0065","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2017.12.016","article-title":"4 weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer: Interim safety analysis of a randomized phase 3 trial","volume":"100","author":"Fonteyne","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euf.2022.09.005","article-title":"Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer: First results from the multicenter phase 3 PROPER trial","volume":"9","author":"Fonteyne","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.radonc.2023.109950_b0075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-06911-4","article-title":"PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial","author":"De Bruycker","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109950_b0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.eururo.2020.08.023","volume":"79","author":"Boev\u00e9","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2023.109950_b0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.aca.2018.06.065","article-title":"A validated multi-matrix platform for metabolomic fingerprinting of human urine, feces and plasma using ultra-high performance liquid-chromatography coupled to hybrid orbitrap high-resolution mass spectrometry","volume":"1033","author":"De Paepe","year":"2018","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.radonc.2023.109950_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00785","article-title":"SplinectomeR enables group comparisons in longitudinal microbiome studies","volume":"9","author":"Shields-Cutler","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.radonc.2023.109950_b0100","unstructured":"vegan: Community Ecology Package. 2022. p. Oksanen, J. et al."},{"key":"10.1016\/j.radonc.2023.109950_b0105","doi-asserted-by":"crossref","unstructured":"Reyman M, van Houten MA, van Baarle D, Bosch AATM, Man WH, Chu MLJN, Arp K, Watson RL, Sanders EAM, Fuentes SA, Bogaert D. Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. Nat Comm. 2019.","DOI":"10.1038\/s41467-019-13014-7"},{"key":"10.1016\/j.radonc.2023.109950_b0110","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.2c05371","article-title":"Dual UHPLC-HRMS metabolomics and lipidomics and automated data processing workflow for comprehensive high-throughput gut phenotyping","author":"Vangeenderhuysen","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.radonc.2023.109950_b0115","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ Sci Tech"},{"key":"10.1016\/j.radonc.2023.109950_b0120","doi-asserted-by":"crossref","unstructured":"van den Berg RA, Hoefsloot HCJW, J.A., Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006;7.","DOI":"10.1186\/1471-2164-7-142"},{"key":"10.1016\/j.radonc.2023.109950_b0125","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","article-title":"Microbiota- and Radiotherapy-Induced Gastrointestinal Side-effects (MARS) study: A large pilot study of the microbiome in acute and late-radiation enteropathy","volume":"25","author":"Ferreira","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2023.109950_b0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gutjnl-2017-313789","article-title":"Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction","volume":"67","author":"Gerassy-Vainberg","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2023.109950_b0135","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/jcmm.14289","article-title":"Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy","volume":"23","author":"Wang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.radonc.2023.109950_b0140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijrobp.2022.04.037","article-title":"Microbiome dynamics during chemoradiation therapy for anal cancer","volume":"113","author":"Lin","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2022.08.007","article-title":"Irradiation-induced intestinal injury is associated with disorders of bile acids metabolism","volume":"115","author":"Guo","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.radonc.2023.109950_b0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","article-title":"The gut microbiota and host health: a new clinical frontier","volume":"65","author":"Marchesi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2023.109950_b0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.radonc.2020.01.011","article-title":"Fecal microbiota transplantation: A promising treatment for radiation enteritis?","volume":"143","author":"Ding","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109950_b0165","doi-asserted-by":"crossref","first-page":"e0247905","DOI":"10.1371\/journal.pone.0247905","article-title":"A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers","volume":"16","author":"El Alam","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109950_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2019.12.040","article-title":"Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer","volume":"107","author":"Mitra","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0175","article-title":"Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109950_b0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2014.10.023","article-title":"Intestinal microbiota-derived metabolomic blood plasma markers for prior radiation injury","volume":"91","author":"Broin","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109950_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102973","article-title":"Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy","volume":"59","author":"Ng","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2023.109950_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.777160","article-title":"Carbon ion radiotherapy evokes a metabolic reprogramming and individualized response in prostate cancer","volume":"9","author":"Ning","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.radonc.2023.109950_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-030-22254-3_11","article-title":"Discovery of metabolic biomarkers predicting radiation therapy late effects in prostate cancer patients","volume":"1164","author":"Cheema","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.radonc.2023.109950_b0200","doi-asserted-by":"crossref","unstructured":"Asnicar F, Berry SE, Valdes AMN, L.H., Piccinno G, Drew DA, Leeming E, Gibson R, Le Roy C, Khatib HA, Francis L, Mazidi M, Mompeo O, Valles-Colomer M, Tett A, Beghini F, Dubois L, Bazzani D, Thomas AM, Mirzayi C, Khleborodova A, Oh S, Hine R, Bonnett C, Capdevila J, Danzanvilliers SG, F., Geistlinger L, Waldron L, Davies RH, G., Wolf J, Ordov\u00e1s JM, Gardner C, Franks PW, Chan AT, Huttenhower C, Spector TD, Segata N. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med. 2021;27.","DOI":"10.1038\/s41591-020-01183-8"},{"key":"10.1016\/j.radonc.2023.109950_b0205","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1572-0241.2008.01868.x","article-title":"The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea","volume":"103","author":"Manichanh","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.radonc.2023.109950_b0210","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","article-title":"Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration","volume":"159","author":"Sorrentino","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.radonc.2023.109950_b0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.toxlet.2014.10.011","article-title":"Diet supplementation with cholic acid promotes intestinal epithelial proliferation in rats exposed to \u03b3-radiation","volume":"232","author":"Hagio","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.radonc.2023.109950_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ab.2017.03.007","article-title":"Analysis of short-chain fatty acids in human feces: A scoping review","volume":"526","author":"Primec","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.radonc.2023.109950_b0225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00066-018-1395-y","article-title":"Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial","volume":"195","author":"Rammant","year":"2019","journal-title":"Strahlenther Onkol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:41Z","timestamp":1759123721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"alternative-id":["S0167814023898449"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109950","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome and metabolome dynamics during radiotherapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109950"}}